EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 76 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $14,668,224 | 8.18% |
| Caligan Partners LP | 435,298 | $1,523,543 | 1.27% |
| ACUTA CAPITAL PARTNERS, LLC | 303,396 | $1,061,886 | 0.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,347,897 | $11,717,640 | 0.49% |
| Samsara BioCapital, LLC | 480,000 | $1,680,000 | 0.36% |
| RA Capital Management | 3,370,506 | $11,796,771 | 0.24% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 201,810 | $706 | 0.11% |
| Legato Capital Management LLC | 76,130 | $266,455 | 0.05% |
| BARD ASSOCIATES INC | 30,674 | $107,359 | 0.05% |
| LEVIN CAPITAL STRATEGIES, L.P. | 79,000 | $276,500 | 0.04% |